A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage

The content presented here was prepared by independent authors under the editorial supervision of OncoEd and is not endorsed or sanctioned by the conference.
Date: February 22-24, 2007
Location: Orlando, Florida
Author:

Prostate Cancer: Updates from the 2007 ASCO Prostate Cancer Symposium
E. David Crawford, MD, Professor of Surgery and Radiation Oncology, Head, Urologic Oncology, University of Colorado Health Sciences Center 

News Stories
Maintenance Rituxan® Is Safe for Follicular Lymphoma (7/8/2008)

Gemcitabine, Rituximab, Oxaliplatin, and Pegfilgrastim Active for Relapsed NHL (6/27/2008)

Lumiliximab and FCR Promising for Relapsed CLL (6/26/2008)

Flavopiridol Has Significant Activity in Relapsed Chronic Lymphocytic Leukemia (6/25/2008)

Sprycel® Effective for Patients with Newly Diagnosed CML (6/24/2008)

More ASCO 2008 News »
Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.